We found that ACE2 and TLR7 are expressed at low levels in healthy brains, slightly increased in AD patients, while TMPRSS2/4 and SLC6A19 are extremely low-expressed, with nearly no expression, in AD patients. The gene discussed is SLC6A19; the disease is Alzheimer disease.